Research on anticervical cancer is urgently required to enhance clinical outcomes. As a main anticancer drug for cervical carcinoma, cisplatin (CIS) has been used for a lot of years in clinical therapy. However, serious adverse effects including nephrotoxicity and neurotoxicity limit its long-term treatment. Our main goal of this study is to investigate the improvement of Ganoderma lucidum polysaccharides (GPS) on CISinduced antitumor effect of in U14 cervical carcinoma-bearing mice. The results showed that GPS + CIS could not only inhibit the growth of the tumor but also improve the spleen and thymus indexes. Moreover, little toxicological effects were observed on hepatic function and renal function in GPS + CIS treated mice bearing U14 tumor cells. Further analysis of the tumor inhibition mechanism indicated that the number of apoptotic tumor cells increased significantly, the expression of Bax increased and the expression of Bcl-2 decreased dramatically in cervical cancer sections after oral administration of GPS + CIS for 14 days. This GPS/CIS combined therapy represents intriguing therapeutic strategy for U14 cervical carcinoma providing not only superior efficacy but also a higher safety level.
effect, decrease the side effects of chemotherapy, and improve quality of life. 6, 7 Natural polysaccharides are the main bioactive ingredient in natural medicine. 8 Ganoderma lucidum is an edible mushroom and has long been served as a Traditional Chinese Medicine with medicinal properties. Polysaccharides are known the main composition of G. lucidum and possess various pharmacological activities, such as immunomodulatory, antitumor, liver protection, and anti-inflammatory. 9 However, it remains to be investigated whether the combination of G. lucidum polysaccharides and CIS can be applied to cervical cancer treatment.
The previous study has reported that the G. lucidum polysaccharides possess the activities of immunomodulatory and antioxidant in cervical carcinoma rat. 10 In the present research, we hypothesized that G. lucidum polysaccharides could assuage CIS treatment induced immunosuppression and organ damage, and to improve the antitumor activity of CIS. Hence, the purpose of the present study to demonstrate whether the combined use of G. lucidum polysaccharides (GPS) and CIS could be effective in cervical carcinoma treatment, therefore we investigated the effects of G. lucidum polysaccharides plus CIS combination in U14 cervical carcinoma-bearing mice. 
| MATERIAL AND METHODS

| Chemicals and reagents
| Preparation of GPS
G. lucidum polysaccharide (GPS) was prepared from the fruiting body of G. lucidum by traditional hot water extraction according to method with minor modification. 11 Briefly, the extraction condition was: an extraction temperature of 95 C, water/solid of 15:1, and extraction time of 3 hours. The extract was centrifuged to obtain the supernatant and precipitated with 85% ethanol at 2 C for 12 hours after concentration under vacuum. GPS was obtained by lyophilized and deproteinated by Sevag method. The content of polysaccharides was 90.13% and measured by phenol-sulfuric acid method. Besides, another four groups of mice were treated as the above protocol for survival time study. All mice were observed for 28 days after the U14 cervical carcinoma challenge.
| Cell line and animals
| Analysis of liver and renal function
Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum creatinine (CRE), and serum urea nitrogen (BUN) were determined by commercial assay kits on the basis of manufacturer's specification (Nanjing Jiancheng Bioengineering Institute). 
|
| Immunohistochemical analysis of the expression of Bax and Bcl-2
The collected tumor tissue of mice was fixed in 10% formalin, and 
| Statistical analysis
All experimental results were reported as the means ± SD and the experiment were replicated twice. The differences between groups were estimated by one-way ANOVA and using SPSS software (version 16.0); P < 0.05 was usually considered as statistically significant. 
| Treatment effects on immune organs index of U14-bearing mice
To investigate potential immunomodulatory effects of CIS treatment with or without GPS, the spleen and thymus indexes of treated mice were investigated. As displayed in Table 1 , compared with the model group, the spleen and thymus index were obvious decrease in CIS group (P < 0.05), whereas there was an obvious increase in the thymus index and a notable decrease in the spleen in the GPS alone or GPS + CIS groups (P < 0.05). These results implied that immunosuppression could be caused by CIS treatment and that GPS may potentially prevent the immunosuppressive effect of CIS to certain a degree.
| Treatment effects on the T cells subsets in peripheral blood
Immunomodulatory actions of CIS treatment with or without GPS were further investigated on the cellular level. As showed in Figure 1A The data were expressed as the mean ± SD (n = 10/group). *P < 0.05 (vs the model group).; **P < 0.01 (vs the model group).; ***P < 0.05 (vs the CIS group).; **** P < 0.01 (vs the CIS group).
compared with model group (P < 0.05), which showed that their capacity of antitumor effects by improving T cells immune function.
| Effect of combined therapy on survival in U14-bearing mice
As showed in Figure 1D , the survival rate of all groups of mice was observed after U14 cervical carcinoma challenge. The survival rate of U14 cervical carcinoma-bearing mice treatment with GPS alone or CIS alone was obviously higher compared with the mice in MC group (P < 0.05). Furthermore, the mice of combined therapy group had an obviously higher survival rate than the mice in GPS group or CIS group (P < 0.05).
| Treatment effects on WBC count of mice
As displayed in Table 1 , CIS alone treatment obviously decreased the WBC count (P < 0.01 vs model group). Compare with the model group, GPS alone treatment also decreased the WBC count (P < 0.01 vs model group). Compared with the CIS alone treatment, the WBC count of the combination treatment exhibited trends of being lower than that in the CIS group (P < 0.05 vs model group).
| Treatment effects on apoptosis of tumor cells
Apoptosis of tumor tissue section was further measured by the TUNEL straining method. As displayed in Figure 2A ,C, the number of apoptotic 
| Treatment effects on protein expression of Bax and Bcl-2 in tumor tissues
In order to further investigate the mechanism of CIS + GPS mediated apoptosis in tumor tissue. The protein expression of Bax and Bcl-2 was measured by immunohistochemical assay. As showed in Figure 3 , the level of the proapoptotic protein Bax was obviously increased and the level of antiapoptotic protein Bcl-2 was significantly decreased in the CIS or GPS treatment group when compared with the model group (P < 0.05; P < 0.01). Moreover, in the CIS + GPS group, the protein level of Bax was highest and the level of Bcl-2 was the lowest of the four groups. These results implied that GPS + CIS induced apoptosis is mediated by modulating Bcl-2 and Bax family protein in tumor tissues of U14-bearing mice.
| Toxicological effects of CIS + GPS treatment in U14-bearing mice
The showed by a recent study to exert antitumor activity and result in attracting considerable attention. 9 Therefore, in the present study, we investigated the improvement effects of adjuvant treatment with GPS in U14 bearing mice. Our results indicated that the combination of CIS with GPS improves the antitumor effect of CIS and lower organs toxicity in U14-bearing mice.
Previously study has shown that novel polysaccharides isolated from G. lucidum possess higher antitumor activity by combination with cyclophosphamide in sarcoma 180-bearing mice 13 and G. lucidum polysaccharides could improve chemotherapy-related fatigue via regulation oxidative stress and reduction of nephrotoxicity, these results indicated the synergistic effects of GPS on antitumor effect with cisplatin. 14 Similarly, in our present research, we observed that GPS treatment alone also suppressed the growth of U14 cervical carcinoma. Moreover, GPS and CIS combination administration indicated a trend of possessing a higher capacity for suppressing U14 cervical tumor growth than CIS administration alone, which implying that the antitumor effect of the CIS could be enhanced by GPS supplementation.
Apoptosis is a vital homeostatic mechanism for a host to equilibrate the cell death and cell division, and as a consequence it is employed by the host to sustain the proper number of cells in the tissue. Induction of cancer apoptosis is a common phenomenon by anticancer treatment and has been recognized as an effective strategy for the development of anticancer drug. 15 The current research showed that GPS alone or combination with CIS suppressed the growth of tumor in association with apoptosis. Apoptosis is regulated by proapoptotic and antiapoptotic effectors, which involves a lot of proteins. Bcl-2 family proteins, such as the antiapoptotic protein Bcl-2 and the proapoptotic protein Bax act as vital control points in the mitochondrial-mediated apoptotic pathway. 16 These results of the current research indicated that combined therapy indicated a tendency of possessing a higher capacity in Interestingly, GPS or CIS + GPS could also reduce the WBC count of carcinoma-bearing mice compared to the MC group. Indeed, the WBC count is an indicator of immunosuppression, it is also another marker of nonspecific inflammation. The effect of GPS or CIS + GPS on suppressing WBC count is not relevant to immune organs protective effect possibly due to the anti-inflammatory activity of GPS. 27 The previous studies showed that tumor-induced increased of WBC count, and anti-inflammatory ingredients Brucea javanica Oil or the glycyrrhetinic acid modified curcumin-loaded cationic liposomes could suppress WBC count. These findings were consistent with our results. 28, 29 Cisplatin (CIS) is a synthetic antitumor drug commonly used in clinically chemotherapy for the treatment of several malignancies.
However, nephrotoxicity and hepatotoxicity remain the serious drawback in high dose of CIS chemotherapy. 30, 31 BUN and CRE are the principal waste products that are eliminated from the kidneys. The increase in serum levels of BUN and CRE is used as a marker of CIS-induced nephrotoxicity. 32 In addition, the obvious increase of the serum levels of AST and ALT is commonly used as an indicator for liver damage. 33 In present research, the results showed that treatment CIS to U14-bearing mice induced an obvious increase in the serum levels of AST, ALT, BUN, and CRE, indicating that acute liver and renal failure, which can be obviously ameliorated by GPS supplementary treatment. These findings are consistent with previous studies that G. lucidum fruiting bodies protects kidney and liver function. 27, 34 In conclusion, the combined therapy of GPS and CIS indicates a better antitumor activity than GPS or CIS treatment alone in U14-bearing mice.
In addition, GPS and CIS combination treatment can increase spleen and thymus indices, and improve body immunity by the promotion of T lymphocytes subsets, the CD4 + /CD8 + T-cell ratio when compared to CIS treatment alone. Furthermore, the combination treatment can improve liver and renal function when compared to CIS treatment alone. This research implies that combination therapy of GPS with CIS can enhance the antitumor activity of CIS and can assuage the immunosuppression and organ toxicity caused by CIS treatment in U14-bearing mice, which represent potentially useful medicinal functions in prevention of cervical cancer.
